Safety and Feasibility of Collateral Blood Flow Augmentation After Intravenous Thrombolysis
Authors:
- 1 April 2011
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 42 (4) , 1135-1137
Abstract
Background and Purpose—: Collateral flow augmentation using partial aortic occlusion may improve cerebral perfusion in acute stroke. We assessed the safety and feasibility of partial aortic occlusion immediately after intravenous tissue plasminogen activator. Methods—: We conducted an open-label pilot study of partial aortic occlusion after thrombolysis. The primary end point was all serious adverse events within 30 days of treatment. Results—: None of the 22 patients enrolled developed symptomatic parenchymal hemorrhages. Asymptomatic hemorrhagic transformation occurred in 9 patients. Procedure-related adverse events were limited to groin complications (n=13). Seventy-seven percent of patients experienced neurological improvement (≥4-point improvement of the National Institutes of Health Stroke Scale score). Conclusions—: Partial aortic occlusion as an adjunct to thrombolysis in the treatment of acute stroke appears safe. Studies aimed at determining the efficacy of this therapeutic approach are warranted. Clinical Trial Registration Information—: URL: http://www.clinicaltrials.gov . Unique Identifier: NCT01006993.Keywords
This publication has 9 references indexed in Scilit:
- Partial Intra‐Aortic Occlusion Improves Perfusion Deficits and Infarct Size Following Focal Cerebral IschemiaJournal of Neuroimaging, 2010
- Partial Occlusion of the Descending Aorta Increases Cerebral Blood Flow in a Nonstroke Porcine ModelCerebrovascular Diseases, 2009
- Aortic occlusion for cerebral ischemia: From theory to practiceCurrent Cardiology Reports, 2008
- Refining the Perfusion–Diffusion Mismatch HypothesisStroke, 2005
- Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trialsThe Lancet, 2004
- Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen ActivatorStroke, 2001
- Timing of Recanalization After Tissue Plasminogen Activator Therapy Determined by Transcranial Doppler Correlates With Clinical Recovery From Ischemic StrokeStroke, 2000
- Mechanism of hemodynamic responses to occlusion of the descending thoracic aortaAmerican Journal of Physiology-Heart and Circulatory Physiology, 1980
- Experimental augmentation of cerebral blood flow by intermittent aortic occlusionJournal of Neurosurgery, 1972